ExploreWatchlistsPricing
  1. JP-listed companies
  2. GNI Group Ltd.
  3. Financials
  4. Retained earnings

GNI Group Ltd. (2160)

Market cap
¥191.6B
P/E ratio
GNI Group develops and manufactures pharmaceuticals and medical devices, serving global markets with key products like Aisuryui in China and biomaterials in the US.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndRetained earnings (Million JPY)YoY (%)
Dec 31, 20255,644-42.93%
Dec 31, 20249,889+12.49%
Dec 31, 20238,791+1162.36%
Dec 31, 2022696+126.43%
Dec 31, 2021308-150.58%
Dec 31, 2020-608-65.55%
Dec 31, 2019-1,765+481.10%
Dec 31, 2018-304-95.52%
Dec 31, 2017-6,779+27.90%
Dec 31, 2016-5,300+7.35%
Dec 31, 2015-4,937+6.20%
Dec 31, 2014-4,649

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat